These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37956243)

  • 1. Uptake and Discontinuation of Pre-Exposure Prophylaxis Among Uninsured Transgender and Cisgender Women: A Public-Private Partnership Model in North Carolina.
    Zarwell M; Witt B; Marin-Cespedes S; Gorman B; Kumtap MU; Hoff R; Rysbayeva A; Jha P; Boehm EL; Harihar S; Issel LM; Robinson P
    AIDS Patient Care STDS; 2023 Nov; 37(11):525-534. PubMed ID: 37956243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Disease Intervention: Exploring an Expanded Role for Partner Services in the MATRix-NC Demonstration Project.
    Hurt CB; Morrison AS; Guy J; Mobley VL; Dennis AM; Barrington C; Samoff E; Hightow-Weidman LB; McNeil CJ; Carry MG; Hogben M; Seña AC
    Sex Transm Dis; 2022 Feb; 49(2):93-98. PubMed ID: 34475364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preexposure Prophylaxis Outcomes in an Urban Community in North Carolina: Discontinuation of Care and Sexually Transmitted Infections.
    Clement ME; Nicchitta M; Sun Y; Ellis A; Chakraborty H; McGee K; Eagle C; Frye J; Taylor D; Okeke NL; Johnston B; Seña AC; McKellar M
    Sex Transm Dis; 2021 Mar; 48(3):183-188. PubMed ID: 33003182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in HIV/Sexually Transmitted Infection Prevalence and Prevention Among the Partners of Transgender and Nonbinary People.
    Tordoff DM; Minalga B; Perry NL; Gross B; Khosropour CM; Glick SN; Barbee LA; Duerr A;
    Sex Transm Dis; 2023 May; 50(5):280-287. PubMed ID: 36881439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections.
    Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the Integration of Syndromic versus Etiological Management of Sexually Transmitted Infections Into HIV Pre-Exposure Prophylaxis Services for Adolescent Girls and Young Women, in South Africa.
    Mullick S; Cox LA; Martin CE; Fipaza Z; Ncube S
    J Adolesc Health; 2023 Dec; 73(6S):S67-S72. PubMed ID: 37953011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019.
    Watson DL; Shaw PA; Petsis DT; Pickel J; Bauermeister JA; Frank I; Wood SM; Gross R
    J Int AIDS Soc; 2022 Feb; 25(2):e25867. PubMed ID: 35192740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature.
    Baldwin A; Light B; Allison WE
    Arch Sex Behav; 2021 May; 50(4):1713-1728. PubMed ID: 34075504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System-A Cohort Study.
    Hechter RC; Bruxvoort KJ; Zhou H; Towner WJ; Contreras R; Schumacher CM; Grant DL; Jones J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):1-8. PubMed ID: 35499561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
    Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States.
    Clement ME; Johnston BE; Eagle C; Taylor D; Rosengren AL; Goldstein BA; Seña AC
    AIDS Patient Care STDS; 2019 Aug; 33(8):366-371. PubMed ID: 31233329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introducing a Sexual Wellness Clinic to an At-Risk Population Through the Emergency Department.
    Hazra A; Stanford K; Schneider J; Davis A
    Acad Med; 2023 Jun; 98(6S):S60-S62. PubMed ID: 36867003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back2PrEP: Rates of Bacterial Sexually Transmitted Infection Diagnosis Among Individuals Returning to HIV Pre-Exposure Prophylaxis Care: A Retrospective Review of a New York City Comprehensive HIV Prevention Program.
    McLean J; Bartram L; Zucker J; LaSota E; Carnevale C; Richards P; Perez E; Mori K; Mgbako O; Olender S; Cohall A; Gordon P; Sobieszczyk M
    AIDS Patient Care STDS; 2022 Dec; 36(12):458-461. PubMed ID: 36383140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial.
    Agustí C; Martínez Riveros H; García-Pérez J; Descalzo V; Fernandez G; Ramírez-Marinero A; Gonzalez MV; Díaz Y; Montoro-Fernandez M; Romano-deGea P; Araujo SG; Muntada E; Casabona J
    BMJ Open; 2023 Oct; 13(10):e073459. PubMed ID: 37844988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.